Are we actually asking the question in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort. Here Allen Roberts looks behind the issue at the Australian way of getting things done, and whether that, itself, needs reform. As we seek to move towards 3% of GDP as a measure of the R&D…
Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…
Envirostream to recycle LG lithium batteries Battery recycler Envirostream has signed an exclusive three year agreement with LG Energy Solutions to recycle all its recalled lithium ion batteries collected in Australia. Envirostream, a subsidiary of Lithium Australia, expects significantly increased battery collection volumes equating to 140 percent of the company’s total in FY23. LG has…
Microbial development and contract manufacturing companies Adelaide’s BioCina and Perth’s NovaCina have announced a strategic partnership to provide integrated drug substance and drug product solutions for the pharmaceutical sector. The two companies are buy-outs from the Pfizer pharmaceutical company and share the same investor – private investment firm Bridgewest Group – and will now collaborate…
RM Williams to open flagship store on Friday Apparel company R.M.Williams is preparing to open its flagship store to the public on December 1 in Sydney. The 91-year-old brand will open the store on George Street, in the CBD, and The Sydney Morning Herald reports that, “A customised soundtrack, signature scent and altar to R.M.…
US-based biotech company Moderna has announced the launch of the mRNA Platform Incubator Network, linking Australian organisations with strength in translational and pharmaceutical science, early-phase clinical trials and regulatory science. According to the maker of the Spikevax COVID‑19 vaccine, the group aims to “advance mRNA medicine, foster scientific excellence in clinical translation in Australia and…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Another battery metals factory lost offshore, more to come While Australia talks the big talk about being a critical minerals and battery metals superpower, backed by the $15 billion National Reconstruction Fund, Australian metals companies continue to…
The Victorian government has announced that construction of Moderna’s mRNA vaccine manufacturing facility is ahead of schedule and at the halfway mark, with completion expected next year. State industry minister Ben Carroll visited Monash University’s Clayton precinct on Monday morning, where the US-based biotechnology company will eventually have capacity for 100 million vaccine doses per…
US-based biotech company Moderna has opened its Regional Research Centre for Respiratory Medicines and Tropical Diseases and local headquarters in Melbourne, ahead of the expected opening of their mRNA factory next year. State industry minister Ben Carroll launched the new research centre on Tuesday. It sits next to its headquarters for Australia, New Zealand, South-East…
